Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

Many pre-transplant factors are known to influence the outcome of allogeneic stem cell transplantation (SCT) treatment in myelodysplastic syndromes (MDS). However, patient cohorts are often heterogeneous by disease stage and treatment modalities, which complicates interpretation of the results. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Cremers, E. M. P., van Biezen, A., de Wreede, L. C., Scholten, M., Vitek, A., Finke, J., Platzbecker, U., Beelen, D., Schwerdtfeger, R., Volin, L., Harhalakis, N., Blijlevens, N., Nagler, A., Kröger, N., de Witte, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093200/
https://www.ncbi.nlm.nih.gov/pubmed/27650829
http://dx.doi.org/10.1007/s00277-016-2802-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093200/
https://www.ncbi.nlm.nih.gov/pubmed/27650829
http://dx.doi.org/10.1007/s00277-016-2802-z

Ejemplares similares